Hydrocortisone

Hydrocortisone is a naturally occurring glucocorticoid hormone, identical to cortisol produced by the adrenal glands, that is used therapeutically in feline medicine for its anti-inflammatory and immunomodulatory properties. This medication belongs to the class of short-acting corticosteroids and is considered one of the less potent agents in this drug category, with potency approximately equivalent to the body's natural cortisol production. Hydrocortisone holds a unique position in corticosteroid therapy because it represents the biological standard against which other corticosteroids are compared, and it provides therapeutic options for situations where milder corticosteroid effect is desired or where physiological hormone replacement is needed.

The mechanism of action of hydrocortisone mirrors that of the body's natural cortisol, involving binding to glucocorticoid receptors within cells to influence gene expression and produce anti-inflammatory effects. This interaction results in decreased production of inflammatory mediators, reduced immune cell activation, and stabilization of cellular membranes that would otherwise release inflammatory substances. Because hydrocortisone is bioidentical to natural cortisol, it can serve both pharmacological purposes at higher doses and physiological replacement purposes when the body's own cortisol production is deficient. The drug possesses both glucocorticoid and some mineralocorticoid activity, affecting both inflammation and sodium-potassium balance.

Hydrocortisone is available in multiple formulations that expand its therapeutic utility across different clinical applications. Oral tablets allow systemic therapy for conditions requiring whole-body anti-inflammatory effect or for hormone replacement in adrenal insufficiency. Injectable preparations provide rapid systemic delivery for acute situations. Topical formulations including creams, ointments, and sprays enable localized treatment of skin conditions while minimizing systemic absorption and associated side effects. This variety of delivery options makes hydrocortisone versatile for addressing different types of inflammatory conditions in cats.

As a short-acting corticosteroid with relatively lower potency, hydrocortisone may offer advantages when brief duration of effect is desired or when gradual corticosteroid tapering is being implemented. However, its lower potency means it may not provide sufficient anti-inflammatory effect for severe conditions that require more potent agents like prednisolone or dexamethasone. Veterinarians select hydrocortisone when its specific properties match the clinical needs of the patient, and pet owners should understand that different corticosteroids serve different purposes even though they belong to the same drug class. Proper veterinary supervision ensures appropriate medication selection and monitoring throughout treatment.

The primary indications for hydrocortisone in cats include management of inflammatory skin conditions, localized allergic reactions, and as physiological replacement therapy in cats with adrenal insufficiency. Hydrocortisone's lower potency compared to other corticosteroids makes it particularly suitable for mild to moderate inflammatory conditions where the risks of more potent agents may not be warranted. Additionally, topical hydrocortisone preparations are frequently used for localized skin problems, providing anti-inflammatory effect at the site of application while minimizing systemic exposure.

Inflammatory and allergic skin conditions represent one of the most common applications for hydrocortisone in feline practice, particularly in topical formulations. Cats experiencing localized skin irritation, mild allergic dermatitis, insect bite reactions, or hot spots may benefit from topical hydrocortisone application that reduces inflammation and relieves itching at the affected area. The localized treatment approach limits systemic drug exposure, reducing the potential for the metabolic side effects associated with oral corticosteroid therapy. For cats that groom excessively, preventing ingestion of topical products requires attention to application technique and sometimes the use of protective collars.

Adrenal insufficiency, also known as hypoadrenocorticism or Addison's disease, represents a condition where hydrocortisone serves as physiological hormone replacement rather than pharmacological therapy. Although rare in cats compared to dogs, feline hypoadrenocorticism requires lifelong hormone supplementation because the adrenal glands cannot produce adequate cortisol. Hydrocortisone is bioidentical to the natural hormone and can provide the glucocorticoid replacement these cats require. Treatment aims to restore normal physiological hormone levels rather than achieve the immunosuppressive or anti-inflammatory effects sought in other conditions.

Mild systemic inflammatory conditions that do not require the potency of stronger corticosteroids may be managed with oral hydrocortisone in some cases. The shorter duration of action may be advantageous when corticosteroid effect is needed for limited periods or when establishing a tapering protocol prior to discontinuation. However, for many systemic inflammatory or immune-mediated conditions, veterinarians typically select more potent corticosteroids like prednisolone that provide stronger effect with equivalent or even smaller doses.

Topical hydrocortisone may also be used for otic (ear) conditions as part of combination products addressing ear inflammation, or for ophthalmic conditions when appropriate. These specialized applications require specific veterinary guidance, as inappropriate use of corticosteroids in infected ears or eyes can worsen certain conditions. The selection of hydrocortisone versus other corticosteroids depends on the specific clinical situation, required potency, desired duration of action, and route of administration that best addresses the patient's needs.

Hydrocortisone dosing in cats must be determined by a veterinarian based on the specific condition being treated, whether the goal is anti-inflammatory therapy or physiological hormone replacement, and the route of administration being used. Dosing requirements vary substantially between these different applications, with anti-inflammatory therapy typically requiring higher doses than physiological replacement. The relatively lower potency of hydrocortisone compared to other corticosteroids means that larger milligram doses may be needed to achieve equivalent anti-inflammatory effects, though this varies by clinical situation.

Oral hydrocortisone for systemic therapy is administered according to the veterinarian's prescribed schedule, which may range from multiple times daily due to its short duration of action to once daily depending on the indication. For physiological replacement in adrenal insufficiency, dosing aims to mimic normal cortisol patterns and is calculated based on what the body would normally produce. For anti-inflammatory purposes, doses are typically higher and may be divided throughout the day to maintain consistent drug levels. Administration with food may help reduce potential gastrointestinal upset and is generally recommended unless the veterinarian specifies otherwise.

Topical hydrocortisone application follows specific instructions for the product being used and the area being treated. Thin layers of cream or ointment are typically applied to affected skin areas according to the prescribed frequency, often two to three times daily initially with reduction as the condition improves. Application should be limited to the affected area rather than large body regions to minimize systemic absorption. Pet owners must prevent cats from immediately licking the application site, which may require distraction, Elizabethan collars, or timing applications before feeding or play. Sprays are applied as directed, typically from a specified distance to achieve appropriate coverage.

Treatment duration depends on the underlying condition and treatment goals. Topical therapy for acute skin inflammation may be brief, lasting only until the localized problem resolves. Systemic anti-inflammatory therapy follows principles similar to other corticosteroids, with treatment continuing until the condition is controlled and then tapering if extended therapy was needed. Physiological replacement for adrenal insufficiency is lifelong, as the underlying hormone deficiency is permanent. The veterinarian provides guidance on expected treatment duration and criteria for adjusting or discontinuing therapy.

Missed doses of oral hydrocortisone should generally be given when remembered, unless the next scheduled dose is near. The short duration of action means that missed doses result in gaps in drug coverage more quickly than with longer-acting corticosteroids. Doses should never be doubled to compensate for missed administrations. For topical therapy, missed applications have less systemic significance, and pet owners can simply apply the next dose at the regular time or when they remember if continuing on schedule is not possible. Consistent adherence to the prescribed regimen optimizes treatment outcomes.

Discontinuation of hydrocortisone therapy requires consideration of treatment duration and the body's adrenal function. Brief courses may be stopped without tapering, while extended systemic therapy typically requires gradual dose reduction to allow the adrenal glands to resume normal cortisol production. For cats receiving hydrocortisone for adrenal insufficiency, discontinuation is not appropriate as the medication is providing essential hormone replacement. Any changes to the treatment regimen should be made only under veterinary guidance.

Hydrocortisone, like all corticosteroids, can produce side effects, though its lower potency and shorter duration of action may result in less pronounced adverse effects compared to more potent agents when used at appropriate doses. Topical formulations generally cause fewer systemic side effects than oral or injectable routes, though local skin reactions and systemic absorption with extensive application remain possible. Understanding potential side effects enables pet owners to monitor appropriately and communicate effectively with their veterinary team.

Common side effects associated with systemic hydrocortisone use include increased thirst and urination, resulting from the drug's effects on kidney function and fluid regulation. Increased appetite may occur and can lead to weight gain if food intake is not managed. These effects are typically dose-dependent and generally resolve when the medication is reduced or discontinued. The mineralocorticoid activity of hydrocortisone, while less than that of aldosterone, can contribute to sodium retention and potassium loss with higher doses or extended therapy. Behavioral changes such as restlessness or mild agitation may be observed in some cats.

Topical hydrocortisone side effects are primarily local when systemic absorption is limited. Prolonged use on the same skin area can cause local skin thinning, delayed wound healing, and increased susceptibility to skin infections. Hair loss at application sites may occur with extended use. If cats lick the application site and ingest the medication, systemic effects become possible. Signs of excessive licking and ingestion include the systemic side effects mentioned above. Allergic reactions to topical preparations, though uncommon, may manifest as increased redness, irritation, or worsening of the condition being treated.

More significant side effects can occur with higher doses or prolonged systemic therapy. Immune suppression increases susceptibility to infections, which may develop or progress while corticosteroid anti-inflammatory effects mask early warning signs. Metabolic effects including blood glucose elevation are possible, particularly with higher doses, though generally less pronounced than with more potent corticosteroids. Gastrointestinal effects including stomach upset and potential ulceration risk are possible, particularly when combined with non-steroidal anti-inflammatory drugs or in stressed patients.

Serious side effects requiring veterinary attention include signs of infection such as fever, lethargy, loss of appetite, or respiratory symptoms, which may be partially masked by the medication's anti-inflammatory effects. Severe gastrointestinal signs including vomiting, diarrhea, bloody vomit, or black tarry stools warrant immediate evaluation. Significant behavioral changes, neurological symptoms, severe weakness, or any concerning changes in the cat's condition should prompt contact with the veterinary team. For topical products, signs of skin infection, significant worsening of skin condition, or evidence of systemic effects from absorption require veterinary assessment.

Hydrocortisone is contraindicated in cats with known hypersensitivity or allergic reactions to the medication or other corticosteroids. While true allergic reactions to corticosteroids are uncommon, any cat that has experienced previous adverse reactions to corticosteroid products should be carefully evaluated before receiving hydrocortisone. This includes reactions to topical products, as sensitivity may apply across formulations. The veterinary team should be informed of any previous medication reactions to guide safe treatment selection.

Systemic fungal infections represent an important contraindication to systemic hydrocortisone use due to the immunosuppressive effects of corticosteroids. Even though hydrocortisone is less potent than some alternatives, it can still impair immune function sufficiently to allow fungal organisms to proliferate and spread. Cats with diagnosed or suspected systemic mycoses should not receive systemic corticosteroids until the infection is adequately controlled. Topical hydrocortisone should not be applied to skin areas with active fungal infections, as corticosteroids can worsen fungal skin diseases by suppressing local immune defenses.

Topical hydrocortisone has specific contraindications related to skin condition type and integrity. Application to skin with active bacterial or viral infections may worsen these conditions by reducing local immune responses. Cats with skin tuberculosis or certain other infectious skin conditions should not receive topical corticosteroids. Application to open wounds or ulcerated skin should generally be avoided unless specifically directed by the veterinarian. The thin skin around the eyes requires particular caution, and ophthalmic preparations should only be used as specifically prescribed after appropriate evaluation.

Other conditions that may contraindicate or require caution with hydrocortisone include diabetes mellitus, where even less potent corticosteroids can affect blood glucose; gastrointestinal ulceration; viral infections; and conditions where immune suppression could prove harmful. Pregnant cats warrant caution with systemic corticosteroid therapy due to potential effects on fetal development. Nursing mothers require consideration of drug passage into milk. The veterinarian evaluates each cat's complete medical profile to determine whether hydrocortisone in any formulation is appropriate for the individual patient.

Complete disclosure of all medications, supplements, and topical products your cat receives is essential when hydrocortisone therapy is being considered. Drug interactions can affect the safety and efficacy of corticosteroid treatment, and the veterinary team needs comprehensive information to make informed prescribing decisions. This includes oral medications, injectable treatments administered elsewhere, topical products applied to the skin, supplements, and any over-the-counter products being used.

Non-steroidal anti-inflammatory drugs represent a significant interaction concern with hydrocortisone, as with all corticosteroids. Concurrent use of NSAIDs and corticosteroids increases the risk of gastrointestinal ulceration and bleeding. While hydrocortisone is less potent than some alternatives, this interaction remains clinically important. Veterinarians generally avoid prescribing these drug classes together, and pet owners should not give over-the-counter pain relievers to cats receiving hydrocortisone without specific veterinary guidance. Even topical corticosteroid use combined with oral NSAID therapy warrants caution due to potential systemic absorption of the topical product.

Hydrocortisone may interact with other medications affecting metabolism, electrolyte balance, and blood glucose regulation. Drugs that induce or inhibit liver enzymes may alter hydrocortisone metabolism. Diuretics used concurrently may enhance potassium loss, given hydrocortisone's mineralocorticoid activity. Insulin and diabetic medications may require adjustment due to corticosteroid effects on blood glucose, though this is generally less pronounced with hydrocortisone than with more potent corticosteroids. Cardiac glycosides may have enhanced toxicity risk in the presence of corticosteroid-induced electrolyte changes.

Topical drug interactions should be considered when hydrocortisone preparations are applied to skin already receiving other topical treatments. Some combinations may alter drug absorption, effectiveness, or compatibility. Applying multiple topical products to the same area requires veterinary guidance regarding timing and appropriateness of combined use. Certain topical products may contain ingredients that interact with or are incompatible with hydrocortisone preparations. Disclosure of all topical treatments allows the veterinary team to advise on proper use and timing of multiple skin products.

General precautions for hydrocortisone use include ensuring accurate diagnosis before initiating therapy, selecting appropriate formulations and doses, and monitoring for adverse effects throughout treatment. Corticosteroids can mask signs of infection and other conditions, making proper diagnosis essential. Even with lower-potency hydrocortisone, the potential for side effects warrants careful patient selection and monitoring. Accurate weight measurement supports proper dosing of systemic formulations, and assessment of skin condition guides topical product selection and application instructions.

While no specific breed-related sensitivities to hydrocortisone have been established in cats, individual variation in corticosteroid response exists across the feline population. Breeds with higher diabetes prevalence, such as Burmese cats, may warrant additional monitoring when receiving any corticosteroid, though the lower potency of hydrocortisone poses less risk than more potent alternatives. Cats with thin or delicate skin may be more susceptible to local side effects from topical corticosteroid application. The veterinary team considers individual patient factors when prescribing hydrocortisone and monitors response to treatment.

Topical application precautions are particularly important for hydrocortisone products used on cat skin. Application sites should be monitored for signs of infection, skin thinning, or worsening of the condition being treated. Preventing cats from licking application sites is essential to avoid ingestion and systemic absorption. Elizabethan collars or other protective measures may be necessary, particularly for accessible body areas. Long-term topical use on the same area requires veterinary monitoring for local adverse effects. Application near the eyes or on mucosal surfaces requires specific veterinary guidance.

Monitoring during hydrocortisone treatment varies based on route of administration and treatment duration. Systemic therapy monitoring includes observation for increased thirst, urination, and appetite, as well as signs of infection or other complications. Blood work may be recommended for extended systemic therapy to assess electrolytes and metabolic parameters. Topical therapy monitoring focuses on the treated area, watching for improvement in the condition, signs of local side effects, or evidence of infection. Any worsening of the condition or concerning symptoms should prompt veterinary communication.

Special population considerations apply to geriatric cats, kittens, and cats with concurrent medical conditions. Older cats may have thinner skin more susceptible to topical corticosteroid side effects and may have underlying conditions that systemic corticosteroids could worsen. Kittens generally should not receive corticosteroid therapy unless necessary, and the lowest effective dose and potency should be used. Cats with diabetes, kidney disease, heart conditions, or other chronic illnesses require individualized evaluation regarding hydrocortisone use.

Hydrocortisone products should be stored according to the manufacturer's instructions provided with each specific formulation. Oral tablets typically require storage at controlled room temperature between 15 and 30 degrees Celsius, protected from excessive heat, moisture, and light. Topical creams and ointments generally have similar storage requirements, and tubes should be kept tightly capped when not in use to prevent drying or contamination. Topical sprays should be stored according to label instructions, which typically include keeping them away from heat sources and open flames due to propellant contents. All products should be kept in their original containers to maintain proper labeling and protect from environmental factors.

Specific formulation considerations affect hydrocortisone storage requirements. Injectable preparations, maintained at veterinary facilities, may have different temperature requirements depending on the product. Compounded preparations should be stored according to the compounding pharmacy's instructions, which may differ from commercial product guidelines. Ophthalmic preparations require careful storage and handling to maintain sterility, typically with specific temperature requirements noted on the packaging. Multi-dose topical products should be handled to avoid contaminating the product, which may involve not touching tube tips to skin or other surfaces.

Safe handling and disposal practices protect household members and ensure proper medication management. Hydrocortisone products should be stored in locations inaccessible to children and other pets. While hydrocortisone is less potent than some corticosteroids, accidental ingestion should still be avoided. Topical products accidentally ingested in small amounts are generally not dangerous but should be prevented. Expired or unused hydrocortisone should be disposed of according to local pharmaceutical waste guidelines, which may include take-back programs, pharmacy disposal, or specific home disposal methods. Topical products should not be shared between pets without veterinary guidance, as different conditions and patients may require different products or concentrations.

Cats of all breeds can generally receive hydrocortisone therapy when appropriately indicated, as no specific breed-related contraindications have been established. The lower potency of hydrocortisone compared to other corticosteroids may make it a more conservative choice for cats of breeds with known predispositions to corticosteroid-sensitive conditions. However, as with all medications, individual variation exists within any breed, and each patient requires individual assessment and monitoring regardless of breed background.

Certain breed predispositions may influence considerations when prescribing hydrocortisone. Burmese cats have higher prevalence of diabetes mellitus, and while hydrocortisone poses less risk of inducing hyperglycemia than more potent corticosteroids, monitoring for metabolic effects remains appropriate. Breeds predisposed to skin conditions may more frequently require topical corticosteroid therapy, and response should be monitored in these individuals. Cats with known breed-related sensitivities to other medications warrant careful observation when starting any new treatment, including hydrocortisone.

Body size affects systemic hydrocortisone dosing, with larger cats receiving appropriately calculated doses based on body weight and smaller cats requiring precise measurement of relatively small doses. The lower potency of hydrocortisone means that dosing variations may have somewhat less dramatic effects than with more potent corticosteroids, but accurate dosing remains important for optimal outcomes. For topical products, the size of the affected area rather than body size primarily determines application amount, though total body surface area may influence potential systemic absorption from extensive applications.

Age-related factors often have greater clinical significance than breed considerations for hydrocortisone therapy. Geriatric cats may have thinner, more fragile skin that is more susceptible to local side effects from topical corticosteroid application, requiring monitoring for skin thinning, bruising, or delayed healing. Older cats may also have concurrent conditions such as diabetes or kidney disease that warrant consideration when using any corticosteroid. Kittens should generally receive corticosteroid therapy only when necessary, with preference for lower-potency options like hydrocortisone over more potent alternatives when corticosteroid use is indicated. The veterinary team considers all relevant factors for each individual patient.

Other corticosteroids used in feline medicine provide a range of potency and duration options for different clinical situations. Prednisolone is often the first-choice systemic corticosteroid for cats, offering greater potency than hydrocortisone with well-established dosing guidelines and reliable efficacy across various conditions. Cats should receive prednisolone rather than prednisone because felines poorly convert prednisone to its active form. Dexamethasone and betamethasone are potent, long-acting options for situations requiring strong or prolonged corticosteroid effect. Methylprednisolone and triamcinolone offer intermediate options. The selection among corticosteroids depends on required potency, desired duration of action, available formulations, and individual patient considerations.

Alternative topical treatments may be considered for skin conditions depending on the specific diagnosis and patient factors. Non-steroidal anti-inflammatory topical products may be appropriate for some conditions while avoiding corticosteroid-related concerns. Topical antibiotics or antifungal preparations address infectious components of skin disease. Medicated shampoos and conditioners provide therapeutic benefits for various dermatological conditions. Topical immunomodulators like tacrolimus offer alternatives for immune-mediated skin conditions. The veterinarian selects topical therapies based on diagnosis, expected response, and individual patient considerations.

Supportive and complementary approaches may accompany hydrocortisone therapy depending on the condition being treated. For skin conditions, identifying and addressing underlying causes such as allergies improves outcomes beyond symptomatic corticosteroid treatment. Fatty acid supplements may support skin health in cats with inflammatory skin conditions. For cats with adrenal insufficiency receiving hydrocortisone replacement, mineralocorticoid supplementation with fludrocortisone or desoxycorticosterone may also be required, as hydrocortisone alone may not adequately address mineralocorticoid deficiency in all patients. Any changes to medications or supplements should be discussed with the veterinary team to ensure compatibility with hydrocortisone therapy and overall treatment goals.